BioSpace News Archive

Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent HAE attacks, building on its deep-seated roots in hereditary angioedema (HAE), today announced that management will participate in a fireside chat at the H.C. Wainwright 1st Annual Hereditary Angioedema (HAE) Conference taking place virtually on July 20, 2022.

Lightsense Technology and Severn Safety Supply today announced a strategic partnership to help bring the newly launched DrugDetect-F1 to markets in specific areas of North America, utilizing their unique skills and relationships.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched two human monkeypox virus synthetic DNA controls .

Repertoire’s DECODE™ technology will be used to identify the specific T cell receptor (TCR) repertoire in early-stag e cancers treated with chemotherapy-radiation and mid- to late-stage cancers treated with anti-PD-1 therapy.

Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, recently invested in the creation of their Concierge Program, facilitating value-added strategic partnerships with customers through alliance management.

Interventional Orthopedic Solutions Rochester is establishing its commitment to excellence in the field of Regenerative Orthopedics by entering into a partnership with Regenexx®, a worldwide network of specially trained physicians providing advanced, research-driven, regenerative orthopedic treatments.

Gevo, Inc. (NASDAQ: GEVO) announced today that it will host a conference call on Monday, August 8, 2022, at 4:30 p.m. EDT (2:30 p.m. MDT) to report its financial results for the second quarter ended June 30, 2022 and provide an update on recent corporate highlights.

SK Biopharmaceuticals will now be present in four continents: North America , Europe , Asia , and Latin America.

GI Dynamics® Inc. , a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce positive data from the Association of British Clinical Diabetologists (ABCD) Worldwide EndoBarrier Registry and data from use within the National Health Service.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2022, after the close of the stock market on Wednesday, July 27, 2022.